Published On Jan 2, 2023
Oramed Pharmaceuticals Inc. (ORMP) is in the process of trying perfect oral insulin in their phase 3 trial which could potentially be a game changer for the company and for medicine itself.
Disclaimer: I am just an ordinary everyday investor and this is all just my own personal opinion and should not be relied upon for any investing decisions. Please do your own research or seek an authorised financial advisor. Video may contain inaccuracies and some of the information mentioned may have changed or may not be relevant at the time of watching.
show more